Sunday August 9, 2020 09:10

Heathcare Press Release : 30 Jul 2020

SEKISUI Diagnostics Invests GBP14.4 Million in cGMP Biopharma CDMO Heathcare—30 Jul 20

Sekisui announces the decision to invest GBP14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the investment